| 标题： | 保肝药物处方审核中国专家共识 |
| title： | Chinese expert consensus on hepatoprotective drug prescription checking |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 治疗 |
| field： | Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 各级各类医疗机构的药师、医师等相关医务人员，卫生、医保行政主管部门的管理人员等。 |
| Guide users： | Pharmacists, practitioners and other relevant medical personnel in various kinds and grades of facility, and managers of health department and administrative department in charge of medical insurance. |
| 证据分级方法： | 推荐意见的证据质量和推荐强度分级标准采用GRADE法 |
| Evidence grading method： | The GRADE method was used to grade the quality of evidence and the strength of recommendation. |
| 制定单位： | 中国药师协会精准药学工作委员会 |
| Formulating unit： | Precision Pharmacy Working Committee of the Chinese Pharmacists Association |
| 注册时间： | 2023-05-30 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN371 |
| Registration number： | |
| 指南制订的目的： | 本共识是基于法律法规相关规定及可获得的最佳证据制定而成，主要为保肝药物临床合理应用提供一致性、统一性及规范化的处方审核标准共识，促进临床科学合理用药，保障患者用药安全。 |
| Purpose of the guideline： | The consensus is formulated based on the relevant provisions of laws and regulations and the best available evidence, mainly to provide consistency, uniformity and standardized consensus on prescription checking standards for the clinical rational application of hepatoprotective drugs, promote clinical scientific rational drug use, and ensure the safety of drug use for patients. |
最新注册
